[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ATE555108T1 - Polyamide zur behandlung des menschlichen papilloma-virus - Google Patents

Polyamide zur behandlung des menschlichen papilloma-virus

Info

Publication number
ATE555108T1
ATE555108T1 AT07776781T AT07776781T ATE555108T1 AT E555108 T1 ATE555108 T1 AT E555108T1 AT 07776781 T AT07776781 T AT 07776781T AT 07776781 T AT07776781 T AT 07776781T AT E555108 T1 ATE555108 T1 AT E555108T1
Authority
AT
Austria
Prior art keywords
papilloma virus
polyamides
treatment
human papilloma
therapies
Prior art date
Application number
AT07776781T
Other languages
English (en)
Inventor
James Bashkin
Kevin Koeller
Terri Edwards
Christopher Fisher
Original Assignee
Nanovir Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2007/006133 external-priority patent/WO2007103584A2/en
Application filed by Nanovir Llc filed Critical Nanovir Llc
Application granted granted Critical
Publication of ATE555108T1 publication Critical patent/ATE555108T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polyamides (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT07776781T 2006-05-04 2007-05-04 Polyamide zur behandlung des menschlichen papilloma-virus ATE555108T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US79742606P 2006-05-04 2006-05-04
PCT/US2007/006133 WO2007103584A2 (en) 2006-03-09 2007-03-09 Polyamides for treating human papilloma virus
PCT/US2007/010907 WO2007130616A2 (en) 2006-05-04 2007-05-04 Polyamides for treating human papilloma virus

Publications (1)

Publication Number Publication Date
ATE555108T1 true ATE555108T1 (de) 2012-05-15

Family

ID=38862304

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07776781T ATE555108T1 (de) 2006-05-04 2007-05-04 Polyamide zur behandlung des menschlichen papilloma-virus

Country Status (6)

Country Link
US (3) US7589171B2 (de)
EP (1) EP2013200B1 (de)
JP (2) JP5371743B2 (de)
AT (1) ATE555108T1 (de)
ES (1) ES2387249T3 (de)
WO (1) WO2007130616A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8993609B2 (en) * 2006-05-04 2015-03-31 Nanovir, Llc Compounds for treating papilloma virus infection
US20080268022A1 (en) * 2007-02-23 2008-10-30 Mccabe R Tyler Mehtods for treating and preventing ailments caused by human papillomavirus
US9630950B2 (en) 2007-04-23 2017-04-25 California Institute Of Technology Inhibitors for steroid response elements and RNA polymerase II and related methods
US8835480B2 (en) * 2007-04-23 2014-09-16 California Institute Of Technology Inhibitors for steroid response elements and related methods
JP2011213704A (ja) * 2010-03-19 2011-10-27 Keio Gijuku Ｅｂｎａ１機能阻害剤
SG11201401226YA (en) 2011-10-10 2014-05-29 Nanovir Llc Guanidinyl-substituted polyamides useful for treating human papilloma virus
US9982020B2 (en) * 2011-10-10 2018-05-29 Nanovir Llc Antiviral compounds and methods for treating infections caused by double-stranded DNA viruses
WO2016022664A1 (en) 2014-08-05 2016-02-11 Nanovir Llc Antiviral compounds and methods for treating infections caused by double-stranded dna viruses
WO2018044817A1 (en) 2016-08-29 2018-03-08 California Institute Of Technology Compositions and methods for treatment of prostate cancer
WO2023204300A1 (ja) * 2022-04-22 2023-10-26 国立大学法人 東京大学 免疫関連遺伝子の転写抑制剤

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5304121A (en) 1990-12-28 1994-04-19 Boston Scientific Corporation Drug delivery system making use of a hydrogel polymer coating
US5886026A (en) 1993-07-19 1999-03-23 Angiotech Pharmaceuticals Inc. Anti-angiogenic compositions and methods of use
WO1995004732A1 (en) * 1993-08-06 1995-02-16 Synphar Laboratories, Inc. Oligopeptide antiretroviral agents
US6099562A (en) 1996-06-13 2000-08-08 Schneider (Usa) Inc. Drug coating with topcoat
WO1998049142A1 (en) * 1997-04-06 1998-11-05 California Institute Of Technology Dna-binding pyrrole and imidazole polyamide derivatives
EP0968186A1 (de) * 1996-02-26 2000-01-05 California Institute Of Technology Polyamide zum binden an den kleinen graben von doppelsträngiger dna
CN1260006A (zh) * 1996-02-26 2000-07-12 加利福尼亚州技术学院 双链dna和杂环低聚物之间复合物的形成
EP0973740A1 (de) 1996-02-26 2000-01-26 California Institute Of Technology Entwurf, synthese und verwendung von spezifischen dna-bindenden polyamid-liganden
US5998140A (en) * 1996-07-31 1999-12-07 The Scripps Research Institute Complex formation between dsDNA and oligomer of cyclic heterocycles
US6660255B1 (en) * 1996-08-01 2003-12-09 California Institute Of Technology Inhibition of gene transcription by polyamide DNA-binding ligands
CA2342278A1 (en) 1998-09-11 2000-03-23 California Institute Of Technology Inhibition of oncogene transcription by synthetic polyamides
US6673940B1 (en) * 1999-01-08 2004-01-06 California Institute Of Technology Compositions and methods relating to cyclic compounds that undergo nucleotide base pair-specific interactions with double-stranded nucleic acids
CA2450773C (en) * 2001-06-25 2010-08-31 Japan Science And Technology Agency Method of the solid phase synthesis of pyrrole-imidazole polyamide
AU2002363523A1 (en) * 2001-11-07 2003-05-19 Pharmacia Corporation Methods of promoting uptake and nuclear accumulation of polyamides in eukaryotic cells
WO2003040337A2 (en) * 2001-11-07 2003-05-15 Pharmacia Corporation Polyamide modulators of cox2 transcription
WO2004078943A2 (en) * 2003-03-04 2004-09-16 California Institute Of Technology Alternative heterocycles for dna recognition
BRPI0409777A (pt) 2003-04-30 2006-05-30 Pharmacia Corp compostos que apresentam uma parte bicìclica fundida para ligação com o sulco menor de dnadf
WO2005033282A2 (en) 2003-10-01 2005-04-14 Pharmacia & Upjohn Company Llc Polyamide compositions and therapeutic methods for treatment of human papilloma virus

Also Published As

Publication number Publication date
EP2013200A2 (de) 2009-01-14
WO2007130616A2 (en) 2007-11-15
WO2007130616A3 (en) 2008-01-17
US20070293417A1 (en) 2007-12-20
JP2013213219A (ja) 2013-10-17
JP2009536680A (ja) 2009-10-15
ES2387249T3 (es) 2012-09-19
US7589171B2 (en) 2009-09-15
US20090306164A1 (en) 2009-12-10
US20100015084A1 (en) 2010-01-21
US8119677B2 (en) 2012-02-21
JP5371743B2 (ja) 2013-12-18
US9333232B2 (en) 2016-05-10
EP2013200B1 (de) 2012-04-25
JP5796039B2 (ja) 2015-10-21

Similar Documents

Publication Publication Date Title
ATE555108T1 (de) Polyamide zur behandlung des menschlichen papilloma-virus
MA33806B1 (fr) Inhibiteurs du virus de l'hepatite c
EA201190217A1 (ru) Замещенные 2-ацетамидо-5-арил-1,2,4-триазолоны и их применение
CY1114356T1 (el) Αναστολεις του ιου της ηπατιτιδας c
EA200901490A1 (ru) Химические соединения
EA201100505A1 (ru) Органические соединения для применения для лечения бактериальных инфекций
EA200700175A1 (ru) Композиции и способы лечения воспалительных заболеваний
ATE551337T1 (de) Inhibitoren des hepatitis-c-virus
EA201101082A1 (ru) Ингибиторы вируса гепатита с
EA201170508A1 (ru) Производные 1-амино-2-циклобутилэтилбороновой кислоты
EA201170349A1 (ru) Модуляторы mif
EA200702455A1 (ru) Модуляторы индоламин 2,3-диоксигеназы и способы их применения
EA201171208A1 (ru) Ингибиторы вируса гепатита с
EA200900298A1 (ru) Ингибиторы вируса гепатита с
EA200970581A1 (ru) Кристаллическое твёрдое основание разагилина
EA200971074A1 (ru) Антивирусные соединения
MX2013003634A (es) Derivados policiclicos heterociclicos y metodos de uso de los mismos para el tratamiento de enfermedades virales.
EA200870164A1 (ru) Лечение вирусного гепатита
MX2010005244A (es) Composiciones y métodos para la terapia y el diagnóstico de influenza.
EA201100390A1 (ru) Соединения для лечения гепатита с
WO2007095050A3 (en) N-hydroxyguanidines as modulators of indoleamine 2,3-dioxygenase
ATE489957T1 (de) Mittel zur behandlung von entzündlichen erkrankungen
EA201100564A1 (ru) Антипролиферативные соединения
EA201490853A1 (ru) Противовирусные соединения
DE602005009748D1 (de) 3-phenyl-pyrazol-derivate als modulatoren des zur behandlung damit zusammenhängender störungen nützlichen 5-ht-2a-serotonin-rezeptors